Please visit answersincme.com/GVJ860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in neuro-oncology discusses novel adjuvant therapies for patients with newly diagnosed glioblastoma. Upon completion of this activity, participants should be better able to: Recognize the rationale for combining tumor-treating fields (TTFields) with immunotherapy in the adjuvant treatment of newly diagnosed glioblastoma; Compare the clinical impact of emerging TTFields plus immunotherapy regimens and standard of care in the adjuvant treatment of newly diagnosed glioblastoma; and Outline strategies to personalize the selection of adjuvant therapy for patients with newly diagnosed glioblastoma.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related